| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 55 |
| 1 | ENFORTUMAB VEDOTIN | 41 |
| 2 | MYCOPHENOLATE MOFETIL | 17 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 17 |
| 4 | TACROLIMUS | 17 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 6 | TACROLIMUS OINTMENT 0.1% | 17 |
| 7 | PREDNISONE | 12 |
| 8 | GEMCITABINE HYDROCHLORIDE | 11 |
| 9 | GEMCITABINE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INTERLEUKIN-12 HUMAN RECOMBINANT | 1 | 0.0909 |
| 1 | ENFORTUMAB VEDOTIN | 41 | 0.0052 |
| 2 | LUMASIRAN | 1 | 0.0026 |
| 3 | AVELUMAB | 8 | 0.0020 |
| 4 | ERDAFITINIB | 1 | 0.0008 |
| 5 | PEMBROLIZUMAB | 55 | 0.0005 |
| 6 | BASILIXIMAB | 6 | 0.0005 |
| 7 | SODIUM FERRIC GLUCONATE COMPLEX | 1 | 0.0005 |
| 8 | NERATINIB | 1 | 0.0004 |
| 9 | EVEROLIMUS TABLETS | 6 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 61 | 0.0006 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 8 | 0.0004 |
| 2 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 4 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 5 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 8 | Purine Antimetabolite [EPC] | 4 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 11 | 0.0000 |